Drug Type Chemical drugs, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism CH24H inhibitors(Cholesterol 24-hydroxylase inhibitors), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsy | Phase 1 | US | 01 Jul 2015 | |
Nervous System Diseases | Phase 1 | - | - | |
Nervous System Diseases | Phase 1 | - | - |
Phase 1 | 11 | (TAK-935 600 mg) | hmqddxybtm(yqlemcjizm) = obcmuhmzvx vketexkuzy (yseqkzuwsv, yephdfsbef - onopgfcmdx) View more | - | 11 Apr 2017 | ||
(TAK-935 50 mg) | dntrrfflbq(onjuqakgqg) = cboqkjbswm mwqgdvkbmh (firkpdnbhd, iyfrtquysl - tmuzwhifhm) View more |